|

Cannabidiol Clinical Trials

6 actively recruiting trials across 5 locations

Also known as: CBD, CBD Oil, Epidiolex, GWP42003-P

Other1 trial

Cannabidiol for Bipolar Depression (CBD-BD)
Phase 3

Duarte, California1 trial

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

City of Hope Medical Center

Phase 2

Aurora, Colorado1 trial

CBD for Individuals at Risk for Alzheimer's Disease

University of Colorado - Anschutz Medical Campus

Phase 2

Belmont, Massachusetts1 trial

Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder

McLean Hospital

Phase 2

Cambridge, Massachusetts1 trial

Investigating the Effects of Cannabidiol on Social Anxiety Disorder

Massachusetts Institute of Technology

Phase 4

New York, New York1 trial

Study of Cannabidiol and Neuroimaging on Stress

Ichan School of Medicine at Mount Sinai

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.